ADHD can shorten life expectancy by nearly a decade. Yet, many adults go undiagnosed. Here’s what women need to know.

Before lithium became available to treat this potentially devastating illness, bipolar I sufferers experienced repeated ...

BD affects millions but remains misunderstood, underdiagnosed, and underfunded. Researchers are working to change this by ...

Bipolar disorder, characterized by extreme mood ... making it difficult to maintain stability in daily activities. During manic phases, individuals may experience intense excitement and energy ...

The Google cofounder has donated more than $1.5 billion to Parkinson’s research. Now, as he takes on autism, he’s also ...

Biohaven's NDA for Troriluzole was accepted by the FDA, potentially leading to approval in Q3 2025. Click here to find out ...

Tokyo, Japan and Cambridge, UK, 14 February 2025 – Nxera Pharma Co., Ltd. (“Nxera” or “the Company”; TSE 4565) provides an update on operational activities and reports its consolidated results for the ...

The Sandbox Collective’s “Next to Normal” is a cathartic presentation of what it’s like to be human: to feel, to grieve, to ...

A team of Montreal researchers has made a crucial breakthrough in the understanding of bipolar disorder, which could eventually lead to new therapies for those who suffer from it. “In our field, what ...

Patient enrollment advancing in SERENITY At-Home Phase 3 trial of BXCL501 for acute treatment of agitation associated with bipolar disorders or ...

Many people get the “winter blues,” a mild sadness as the days get colder and shorter. But some people experience clinical ...

The inhaled mebufotenin candidate, dubbed GH001, was evaluated in the midstage study of 81 patients with treatment-resistant depression. The 40 patients who received GH001 saw an average 15.2 point ...